These findings extend our prior findings demonstrating that SDC2 can reduce bleomycin- and radiation-induced fibrosis and, importantly, further highlight the therapeutic potential of SDC2 in the treatment of fibrotic lung diseases27,28. Here, SDC2 is linked to fibrosis.